JP2024538258A5 - - Google Patents
Info
- Publication number
- JP2024538258A5 JP2024538258A5 JP2024525118A JP2024525118A JP2024538258A5 JP 2024538258 A5 JP2024538258 A5 JP 2024538258A5 JP 2024525118 A JP2024525118 A JP 2024525118A JP 2024525118 A JP2024525118 A JP 2024525118A JP 2024538258 A5 JP2024538258 A5 JP 2024538258A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- population
- antigen
- tim3
- lag3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306493.4 | 2021-10-26 | ||
| EP21306493 | 2021-10-26 | ||
| PCT/EP2022/080008 WO2023073062A1 (en) | 2021-10-26 | 2022-10-26 | T cell immunotherapy derived from highly functional autologous stem |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538258A JP2024538258A (ja) | 2024-10-18 |
| JP2024538258A5 true JP2024538258A5 (https=) | 2025-11-04 |
Family
ID=78709377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525118A Pending JP2024538258A (ja) | 2021-10-26 | 2022-10-26 | 高機能性自己幹由来のｔ細胞免疫療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250017961A1 (https=) |
| EP (1) | EP4423247A1 (https=) |
| JP (1) | JP2024538258A (https=) |
| CN (1) | CN118251487A (https=) |
| AU (1) | AU2022374955A1 (https=) |
| CA (1) | CA3235307A1 (https=) |
| WO (1) | WO2023073062A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024262636A1 (en) * | 2023-04-26 | 2025-11-06 | Assistance Publique - Hôpitaux De Paris | T cell immunotherapy derived from autologous stem cell memory t cells |
| WO2025210263A1 (en) | 2024-04-05 | 2025-10-09 | Assistance Publique - Hôpitaux De Paris | T cell immunotherapy of cutaneous diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2992551A1 (en) * | 2015-07-21 | 2017-01-26 | Novartis Ag | Methods for improving the efficacy and expansion of immune cells |
| RU2018127657A (ru) * | 2015-12-30 | 2020-01-31 | Новартис Аг | Виды терапии на основе иммуноэффекторных клеток с улучшенной эффективностью |
| EP3701041A4 (en) * | 2017-10-27 | 2021-11-17 | The Trustees of The University of Pennsylvania | METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES ASSOCIATED WITH EXHAUSTED T-CELLS |
-
2022
- 2022-10-26 CA CA3235307A patent/CA3235307A1/en active Pending
- 2022-10-26 US US18/704,487 patent/US20250017961A1/en active Pending
- 2022-10-26 CN CN202280071961.4A patent/CN118251487A/zh active Pending
- 2022-10-26 JP JP2024525118A patent/JP2024538258A/ja active Pending
- 2022-10-26 AU AU2022374955A patent/AU2022374955A1/en active Pending
- 2022-10-26 WO PCT/EP2022/080008 patent/WO2023073062A1/en not_active Ceased
- 2022-10-26 EP EP22812519.1A patent/EP4423247A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU738538B2 (en) | Method for the production of selected lymphocytes | |
| Schultze et al. | CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. | |
| Zuliani et al. | Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy | |
| US20250084145A1 (en) | Method for establishing pluripotent stem cells bearing genes encoding antigen specific t cell receptor | |
| CN112574952B (zh) | 一种工程化人体免疫细胞、其制备方法及应用 | |
| CN107922925A (zh) | 用于自然杀伤细胞扩增的方法 | |
| CN104894068A (zh) | 一种利用CRISPR/Cas9制备CAR-T细胞的方法 | |
| CN115558641B (zh) | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 | |
| CN109082410A (zh) | 外周血单个核细胞诱导的记忆性免疫细胞及应用 | |
| JP2024538258A5 (https=) | ||
| EP2859092B1 (en) | Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying treg cells to produce therapeutic vaccine for treatment of diabetes type 1 | |
| WO2007105797A1 (ja) | 新規なヒトｔ細胞集団 | |
| CN108588022A (zh) | 体外培养富集人cd4+和cd8+ tcm细胞的方法 | |
| EP3936611A1 (en) | Composition, culture medium and method for inducing and/or amplifying tscm in vitro | |
| CA3048831A1 (en) | Method for obtaining monocytes or nk cells | |
| EP2606125B1 (en) | Cells expressing th1 characteristics and cytolytic properties | |
| CN116063449A (zh) | 一种制备肿瘤抗原特异性t细胞的方法 | |
| CN109957543A (zh) | 利用脐带血大量扩增脐血nk细胞的方法 | |
| JPWO2021100585A5 (https=) | ||
| CN114854685B (zh) | 一种肿瘤特异性ctl细胞制备的工艺方法 | |
| CN103911341B (zh) | Th1细胞亚群的制备方法及其在制备抗肿瘤细胞制剂中的应用 | |
| CN110129374B (zh) | 一种rfft细胞的构建方法 | |
| CN109280643B (zh) | 一种rfft细胞 | |
| CN109294995B (zh) | 一种rfft1细胞 | |
| Shevchenko et al. | In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes |